SCHEMBL4785332

SCHEMBL4785332

CC(O)c1cccc(OCCCBr)c1

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.50
TSHR P16473 1/20 0.50
ALDH1A1 P00352 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
LMNA P02545 1/20 0.47
ALOX5 P09917 2/20 0.42
PTGES O14684 1/20 0.42
PPARG P37231 1/20 0.42
PPARA Q07869 1/20 0.42
CACNA1B Q00975 1/20 0.41
CYSLTR2 Q9NS75 3/20 0.40
CYSLTR1 Q9Y271 3/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
NSD2 O96028 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14066695 0.85 CACNA1B (0.53) KDM4ETSHRALDH1A1SMN1; SMN2LMNA
SCHEMBL3034249 0.83 KMT2A (0.53) KDM4ETSHRALDH1A1SMN1; SMN2LMNA
SCHEMBL27717488 0.83 KDM4E (0.49) KDM4ETSHRALDH1A1SMN1; SMN2LMNA
SCHEMBL6513465 0.82 PTGS1 (0.60) KDM4ETSHRALDH1A1SMN1; SMN2LMNA
SCHEMBL9620700 0.81 CYSLTR2 (0.56) TSHRALDH1A1SMN1; SMN2LMNAALOX5
SCHEMBL24080272 0.81 KDM4E (0.61) KDM4ETSHRALDH1A1SMN1; SMN2LMNA
SCHEMBL5209769 0.80 KDM4E (0.44) KDM4ETSHRALDH1A1SMN1; SMN2LMNA
SCHEMBL5209762 0.80 KDM4E (0.44) KDM4ETSHRALDH1A1SMN1; SMN2LMNA
SCHEMBL6055352 0.80 TP53 (0.52) KDM4ETSHRALDH1A1SMN1; SMN2LMNA
SCHEMBL27494801 0.80 MEN1 (0.41) SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008096129-A1 NITROGEN CONTAINING HETROCYCLIC COMPOUNDS USEFUL AS BIFUNCTIONAL MODULATORS OF M3 RECEPTORS AND BETA- 2 RECEPTORS ARGENTA DISCOVERY LTD (GB) 2008-08-14 WO disclosed